GHB

GHB

GHB

Gamma-Hydroxybutric Acid

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 200, 300 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

What is GHB?

GHB is a central nervous system (CNS) depressant that naturally occurs in small amounts in the human brain but is also manufactured synthetically for illicit use. Commonly referred to as the “date rape” drug, it produces sedative, euphoric, and anesthetic effects and has a rapid onset, especially when taken orally. In appearance, GHB is typically found as a clear, oily liquid, though it may also appear as a white powder or crystalline substance. It is often mixed into small containers or disguised in beverages due to its colorless and sometimes slightly salty taste.

Medically, a pharmaceutical form of GHB known as sodium oxybate is FDA-approved for the treatment of narcolepsy with cataplexy and excessive daytime sleepiness. This prescription form is highly regulated and dispensed only through a restricted distribution program. Recreationally, illicit GHB is used for its euphoric and disinhibiting effects, particularly in nightlife settings. It is also known for its role in drug-facilitated sexual assault due to its strong sedative properties, fast absorption, and difficulty to detect without specialized testing.

Effects:

  • Euphoria and increased sociability

  • Relaxation and reduced anxiety

  • Sedation and drowsiness

  • Impaired coordination and slowed reaction time

  • Dizziness or lightheadedness

  • Nausea and vomiting

  • Confusion or disorientation

  • Respiratory depression

  • Memory loss or blackouts

  • Risk of coma or overdose, especially when mixed with alcohol or other depressants

Commons Slang Terms:

  • G

  • Liquid X

  • Liquid G

  • Georgia Home Boy

  • Soap

  • Scoop

  • Cherry Meth

  • Fantasy

  • Grievous Bodily Harm

Legal Status:

GHB is classified in the U.S. as a Schedule I controlled substance when produced or distributed illicitly, meaning it has no accepted medical use and a high potential for abuse. However, its pharmaceutical form (sodium oxybate, brand name Xyrem/Xywav) is classified as Schedule III, but remains under extremely strict regulation. This dual scheduling makes GHB one of the more tightly controlled substances monitored by law enforcement, courts, and treatment programs.

For point-of-care (POC) toxicology testing programs, detecting GHB is challenging because traditional rapid tests do not include GHB. GHB metabolizes quickly and requires specialized laboratory testing (typically GC/MS or LC/MS) for reliable detection. As a result, most POC programs—workplace, government, probation, or treatment—must rely on laboratory confirmation testing when GHB use is suspected. Testing programs may include GHB monitoring in high-risk populations, drug-facilitated assault investigations, or settings where CNS depressant misuse is a concern. Its rapid elimination and limited rapid-testing options make timely collection and lab analysis essential.

Screening Options:

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

GHB

Gabapentin

Gabapentin

GAB

Primary Products

$

DrugSURE® Integrated Test Cups

$

DrugSURE® Dip Tests

$

OralTox® Oral Fluid Tests

ng/ml

Cut-Off Levels

Rapid Urine Test: 1,000, 2,000 ng/mL

Rapid Oral Fluid Test: 25 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What is Gabapentin?

Gabapentin is a prescription medication classified as an anticonvulsant and neuropathic pain agent. It works by modulating certain neurotransmitters to reduce nerve-related pain and stabilize electrical activity in the brain. Medically, it is FDA-approved for treating seizures and postherpetic neuralgia, and is widely prescribed off-label for conditions such as anxiety, fibromyalgia, restless leg syndrome, and general nerve pain.

Gabapentin typically comes in capsules, tablets, or oral solutions. Capsules may be white, yellow, or multicolored depending on strength and manufacturer. Tablets may be scored or film-coated and usually display the dose or manufacturer imprint.

Medically, gabapentin is taken orally in controlled doses. Recreational misuse has increased in recent years, often combined with opioids, sedatives, or alcohol to enhance sedating or euphoric effects. On its own, gabapentin may produce relaxation, mild dissociation, or sedation in high doses. Misuse is most common in populations with substance use disorders due to its ability to potentiate other depressants, despite being traditionally viewed as a low-risk medication.

Effects:

  • Sedation and drowsiness

  • Dizziness or lightheadedness

  • Relaxation and reduced anxiety

  • Mild euphoria in high doses

  • Impaired coordination or slowed motor skills

  • Blurry or double vision

  • Confusion or slowed cognition

  • Swelling in extremities (edema)

  • Nausea or gastrointestinal discomfort

  • Increased risk of respiratory depression when combined with opioids or alcohol

Commons Slang Terms:

  • Gabbies / Gabbies

  • Johnnies

  • Gabba

  • Nerves (street shorthand referencing its nerve-pain use)

  • Penguin pills

  • G-Pins / Pins

Legal Status:

Gabapentin is not federally scheduled under the U.S. Controlled Substances Act. However, due to increasing misuse and involvement in polysubstance overdoses, multiple states (including KY, TN, WV, VA, and others) have reclassified gabapentin as a Schedule V or controlled/monitored prescription drug, requiring enhanced oversight and reporting.

In point-of-care toxicology programs, gabapentin’s legal status impacts testing in several ways:

  • Because it is not a federally controlled substance, gabapentin is not part of standard workplace drug panels and is not required in DOT or other federal testing programs.

  • Rehabilitation, corrections, pain-management, and MAT programs often choose to test for it voluntarily due to its misuse potential and its interaction with opioids.

  • A positive gabapentin result typically requires careful interpretation since many individuals have legitimate prescriptions. Programs must incorporate prescription verification and confirmatory laboratory testing into their workflow.

  • Its emerging status as a drug of concern means more POC devices are beginning to include gabapentin as an optional test parameter in expanded panels.

Screening Options:

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

GHB

Fentanyl

ng/ml

Cut-Off Levels

Rapid Urine Test: 1*, 5**, 10 ng/mL

Rapid Oral Fluid Test: 0.5 ng/mL

**CLIA-Waived Calibrated to Norfentanyl / *CLIA-Waived

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Rapid Oral Fluid Test: 48 Hours

What is Fentanyl?

Fentanyl is a potent synthetic opioid originally developed for medical use in severe pain management, such as post-surgical care, cancer pain, and end-of-life treatment. In clinical settings, fentanyl is administered in forms like transdermal patches, lozenges, injections, and nasal sprays. Even in its legitimate pharmaceutical form, fentanyl is 50–100 times more potent than morphine, making dosage control critical and misuse extremely dangerous.

Illicit fentanyl, now widespread in the drug supply, is produced unlawfully in powder, tablet, or counterfeit pill form. It is often mixed with heroin, cocaine, or methamphetamine—or pressed into pills made to resemble legitimate medications—without the user’s knowledge. This extreme potency and unpredictable contamination make illicit fentanyl a leading cause of overdose deaths. It can be snorted, smoked, ingested, or injected, and even tiny dosing errors can be fatal due to rapid respiratory depression.

Because fentanyl appears in so many adulterated street drugs, its detection is a major priority for workplaces (particularly safety-sensitive roles), courts, treatment programs, and community health initiatives. Rapid toxicology tests are increasingly incorporating fentanyl-specific assays to identify exposure early and support life-saving interventions.

Effects:

  • Extreme pain relief

  • Profound sedation or drowsiness

  • Euphoria followed by heavy “nodding”

  • Slowed breathing (respiratory depression)

  • Constricted “pinpoint” pupils

  • Nausea or vomiting

  • Confusion or disorientation

  • Severe drowsiness leading to unconsciousness

  • High risk of dependence and withdrawal

  • Overdose that can rapidly lead to respiratory arrest and death

Commons Slang Terms:

  • Fenty

  • Fuff

  • Fetty

  • Apache

  • TNT

  • China White (sometimes used, though historically refers to other opioids)

  • Dance Fever

  • Goodfella

Legal Status:

Fentanyl is classified as a Schedule II controlled substance in the United States, indicating legitimate medical uses but an extremely high potential for abuse, addiction, and overdose. Because illicit fentanyl is a major driver of opioid-related fatalities, its detection has become a high-priority analyte in toxicology programs.

For point-of-care rapid testing, fentanyl’s legal and public-health significance has led many employers, government agencies, treatment centers, and community programs to include fentanyl panels even when traditional opioid screens are already in place. Standard opiate immunoassays do not reliably detect fentanyl, so a fentanyl-specific test is necessary to identify exposure.

In regulated or safety-sensitive environments—such as public safety, healthcare, transportation, and government-supervised programs—fentanyl screening supports risk management, compliance, and early intervention. Positive rapid screens generally require confirmatory laboratory testing due to the drug’s medical availability and the serious consequences associated with false positives. Its legal status and prevalence make fentanyl one of the most critical targets in modern rapid toxicology testing.

Screening Options:

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

GHB

Buprenorphine

ng/ml

Cut-Off Levels

Rapid Urine Test: 5, 10 ng/mL

Rapid Oral Fluid Test: 3 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What is Buprenorphine?

Buprenorphine is a semi-synthetic opioid medication used primarily in the treatment of opioid use disorder (OUD). It works as a partial opioid agonist, meaning it activates opioid receptors enough to prevent withdrawal and reduce cravings but not enough to produce the intense euphoria associated with full opioids like heroin or oxycodone. This unique pharmacology allows buprenorphine to stabilize individuals in recovery and reduce the risk of overdose. Medically, it is prescribed in formulations such as Suboxone® (buprenorphine/naloxone), Subutex® (buprenorphine alone), Bunavail®, and Sublocade® (a long-acting injectable). These come as sublingual tablets, films, or monthly injections.

Illicit or non-prescribed buprenorphine can also appear on the street, typically as diverted prescription tablets or films. Recreational misuse is less common than with other opioids due to buprenorphine’s “ceiling effect,” which limits the level of euphoria it can produce. However, some individuals misuse buprenorphine to self-treat withdrawal, maintain opioid dependence without medical supervision, or combine it with other substances. Because of its role in treatment programs, monitoring appropriate use vs. misuse is often necessary.

Effects:

  • Reduced opioid cravings and withdrawal symptoms

  • Mild euphoria at low doses (less than full opioids)

  • Sedation or drowsiness

  • Constipation

  • Headache and nausea

  • Sweating or flushed skin

  • Reduced respiratory depression compared to full opioids

  • Potential for dependence if misused

  • Precipitated withdrawal if taken too soon after other opioids

  • Impaired coordination or slowed reaction time

Commons Slang Terms:

  • Bup

  • Bupe

  • Subs

  • Strips

  • Oranges (referring to Suboxone’s color)

  • Sabox (mispronunciation of Suboxone)

  • Boxes

  • Sobos

Legal Status:

Buprenorphine is classified as a Schedule III controlled substance, meaning it has legitimate medical use but still carries a risk of misuse and dependence. Because it is widely used in medication-assisted treatment (MAT) programs, many clinical and correctional settings actively screen for buprenorphine to confirm treatment adherence or detect non-prescribed use. Its Schedule III status also means diversion is a recognized concern, prompting many programs to implement regular monitoring.

For point-of-care (POC) rapid toxicology testing programs, buprenorphine is a commonly included analyte, especially in addiction treatment centers, recovery monitoring, corrections, and court-ordered programs. Rapid tests help providers quickly determine whether a patient is taking their prescribed medication as directed or using buprenorphine illicitly. Because false positives can occur with structurally similar opioids, laboratory confirmation is recommended for any presumptive positive result. POC testing ensures timely decision-making, supports treatment compliance, and helps reduce diversion by allowing immediate follow-up when results appear inconsistent with prescribed use.

Screening Options:

LEGEND

 

CLIA-Waived Testing Options Available

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Oral Fluid Testing Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

GHB

Bath Salts

Bath Salt

MDVP – Methylenedioxypyrovalerone

ng/ml

Cut-Off Levels

Rapid Urine Test: 1,000 ng/mL

Rapid Oral Fluid Test: 200, 1,000 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What is MDVP?

Methylenedioxypyrovalerone (MDPV) is a powerful synthetic stimulant belonging to the class of drugs known as synthetic cathinones. It acts on the central nervous system by sharply increasing dopamine and norepinephrine levels, leading to intense stimulation, euphoria, and, at higher doses, severe behavioral disturbances. MDPV is not approved for any medical use, and all versions found in the U.S. are illicit. It often appears as a crystalline powder that can be white, off-white, brownish, or even tan. Products have historically been falsely marketed as “bath salts,” “plant food,” or “research chemicals” to evade regulation.

MDPV is typically sold in small packets or baggies and may be ingested, snorted, smoked, or injected. Because it is produced in clandestine labs, purity and potency vary dramatically, increasing the risk of unpredictable and dangerous effects. Recreational users may seek MDPV for its intense stimulant and euphoric properties, but the drug is well-known for triggering severe agitation, paranoia, hallucinations, violent behavior, and medical emergencies. Its unpredictable pharmacology and highly addictive nature make it one of the more dangerous synthetic stimulants encountered in emergency and toxicology settings.

Effects:

  • Intense euphoria and extreme stimulation

  • Rapid heart rate and dangerously elevated blood pressure

  • Severe agitation, anxiety, and restlessness

  • Extreme paranoia or delusional thinking

  • Hallucinations (visual or auditory)

  • Hyperthermia (dangerously high body temperature)

  • Muscle tension, tremors, or seizures

  • Insomnia and prolonged wakefulness

  • Compulsive redosing and high addiction potential

  • Violent behavior or psychosis requiring medical intervention

Commons Slang Terms:

  • Bath salts

  • Plant food

  • Ivory Wave

  • Vanilla Sky

  • Cloud Nine

  • White Lightning

  • Flakka

  • Bloom

Legal Status:

MDPV is a Schedule I controlled substance, meaning it is fully illegal in the U.S. and has no recognized medical use. This classification places it in the same regulatory category as heroin, LSD, and MDMA. Because it is illegal to possess or distribute, its detection is relevant in probation programs, court-ordered monitoring, treatment facilities, and certain workplace or safety-sensitive environments when synthetic drug use is a concern.

However, not all point-of-care rapid toxicology devices detect MDPV or other synthetic cathinones, because these substances are chemically diverse and evolve rapidly. Many programs rely on specialized lab-based testing or expanded screening panels when synthetic stimulants are suspected. For monitoring programs that face elevated risk (e.g., corrections, drug courts, treatment centers), confirming the ability to detect bath salts is crucial because users often do not know exactly which compound they consumed.

In settings where MDPV screening is relevant, programs typically use a combination of:

Rapid “synthetic cathinone” panels (if available), and Laboratory confirmation testing (LC/MS or GC/MS), due to high specificity requirements.

Screening Options:

LEGEND

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Oral Fluid Testing Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

GHB

Barbiturate

ng/ml

Cut-Off Levels

Rapid Urine Test: 200, 300 ng/mL

Rapid Oral Fluid Test: 60 ng/mL

WOD

Window of Detection Times

Urine Specimen: 1 – 3 Days

Oral Fluid Specimen: 48 Hours

What are Barbiturates?

Barbiturates are central nervous system depressants that reduce brain activity and produce calming or sedating effects. Once widely prescribed for anxiety and insomnia, their medical use is now limited due to the significant risks associated with dependence, tolerance, and overdose. Physicians today primarily use certain barbiturates for specific clinical needs such as seizure control, anesthesia induction, and treatment-resistant migraines.

Prescription barbiturates come in regulated tablet, capsule, and liquid forms, each designed for precise medical dosing. Illicit or recreational forms—typically counterfeit pills or misused prescription products—are swallowed or sometimes crushed and snorted to achieve sedation or euphoria. However, the margin between a “desired” effect and life-threatening respiratory depression is extremely small, making recreational misuse particularly dangerous. Their high abuse potential has led to strict scheduling and close monitoring in both healthcare and drug-testing environments.

Effects:

  • Sedation and drowsiness

  • Relaxation and reduced anxiety

  • Impaired coordination and slowed reflexes

  • Blurred speech and cognitive slowing

  • Reduced heart rate and blood pressure

  • Respiratory depression (dose-dependent)

  • Memory impairment or confusion

  • Increased risk of dependence and withdrawal symptoms

  • Mood instability or irritability

  • High overdose potential, especially when combined with alcohol or opioids

Commons Slang Terms:

  • Barbs

  • Downers

  • Reds (typically secobarbital)

  • Blues

  • Goofballs

  • Yellows

  • Toonies

  • Yellow jackets

  • Sleepers

  • Rainbows

Legal Status:

Barbiturates are classified as Schedule II–IV controlled substances in the U.S., depending on the specific drug and its medical use. All barbiturates carry a high potential for dependence and overdose, which is why their prescribing is tightly restricted and closely monitored. This controlled status makes barbiturates an important target for toxicology screening, particularly in environments concerned with impairment, medication misuse, or compliance monitoring.

For point-of-care rapid testing programs—including workplace testing, probation/supervision programs, treatment facilities, and healthcare settings—barbiturates are typically included as a standard drug class on multi-panel rapid screens. Their sedating and impairment-causing effects pose significant safety risks, especially in positions involving driving, machinery, or public safety. Because some barbiturates still have legitimate medical uses, any presumptive positive result must be followed by confirmatory laboratory testing and, when appropriate, verification of a valid prescription. This ensures regulatory compliance, accuracy, and fairness in decision-making across all testing environments.

Screening Options:

LEGEND

 

CLIA-Waived Testing Options Available

 

Integrated Urine Test Cup Options Available

 

Urine Dip Card Test Options Available

 

Oral Fluid Testing Options Available

 

Lab Confirmation Services Available

GET STARTED

Speak with one of our expert consultants today!

Email Us

info@ntsbiz.com

Phone

1-866-989-9300

Address

550 NW 5th St.

Boca Raton, FL 33486 

Monday - Friday

8am - 5pm

Contact us

Call Us

1-866-989-9300

Email Us

info@ntsbiz.com

Our Location

550 NW 77th Street

Boca Raton, FL 33487

Get in touch